{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:53:04Z","timestamp":1758041584924,"version":"3.44.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,11]]},"DOI":"10.7759\/cureus.92051","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:26:39Z","timestamp":1757593599000},"source":"Crossref","is-referenced-by-count":0,"title":["Bilateral Ptosis, Diplopia, and Vertical Gaze Palsy: An Unusual Presentation of Adolescent Aquaporin-4 (AQP4)-Antibody Positive Neuromyelitis Optica Spectrum Disorder"],"prefix":"10.7759","author":[{"given":"Raya","family":"Flayyih","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdalqader","family":"Abujouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waseem","family":"Fathalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.19-2-169","article-title":"Neuromyelitis optica spectrum disorders","volume":"19","author":"Huda S","year":"2019","unstructured":"Huda S, Whittam D, Bhojak M, et al.. Neuromyelitis optica spectrum disorders. Clin Med Jr. 2019, 19:169-176. 10.7861\/clinmedicine.19-2-169","journal-title":"Clin Med Jr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon VA","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, et al.. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004, 364:2106-2112. 10.1016\/S0140-6736(04)17551-X","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk DM","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, et al.. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neur Jr. 2015, 85:177-189. 10.1212\/WNL.0000000000001729","journal-title":"Neur Jr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318248dec1","article-title":"Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays","volume":"78","author":"Waters PJ","year":"2012","unstructured":"Waters PJ, McKeon A, Leite MI, et al.. Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays. Neur Jr. 2012, 78:665-671. 10.1212\/WNL.0b013e318248dec1","journal-title":"Neur Jr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/735486","article-title":"Brain abnormalities in neuromyelitis optica spectrum disorder","volume":"2012","author":"Kim SH","year":"2012","unstructured":"Kim SH, Kim W, Li XF, et al.. Brain abnormalities in neuromyelitis optica spectrum disorder. Mul Scl Rel Dis. 2012, 2012:735486. 10.1155\/2012\/735486","journal-title":"Mul Scl Rel Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2011.03.038","article-title":"Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures","volume":"306","author":"Jarius S","year":"2011","unstructured":"Jarius S, Paul F, Franciotta D, et al.. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. Jr Neuro Sci. 2011, 306:82-90. 10.1016\/j.jns.2011.03.038","journal-title":"Jr Neuro Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-7169-7","article-title":"Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)","volume":"261","author":"Trebst C","year":"2014","unstructured":"Trebst C, Jarius S, Berthele A, et al.. Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS). Jr Neu. 2014, 261:1-16. 10.1007\/s00415-013-7169-7","journal-title":"Jr Neu"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.188","article-title":"Interferon beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers","volume":"67","author":"Palace J","year":"2010","unstructured":"Palace J, Leite MI, Nairne A, Vincent A. Interferon beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neur. 2010, 67:1016-1017. 10.1001\/archneurol.2010.188","journal-title":"Arch Neur"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.216","article-title":"Failure of natalizumab to prevent relapses in neuromyelitis optica","volume":"69","author":"Kleiter I","year":"2012","unstructured":"Kleiter I, Hellwig K, Berthele A, et al.. Failure of natalizumab to prevent relapses in neuromyelitis optica. Arch Neur. 2012, 69:239-245. 10.1001\/archneurol.2011.216","journal-title":"Arch Neur"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/aian.AIAN_496_18","article-title":"Neuromyelitis optica spectrum disorder with vertical gaze palsy and hypersomnolence","volume":"22","author":"Mathew J","year":"2019","unstructured":"Mathew J, Mohan M, Menon A. Neuromyelitis optica spectrum disorder with vertical gaze palsy and hypersomnolence. Ann Ind Aca Neu. 2019, 22:530-532. 10.4103\/aian.AIAN_496_18","journal-title":"Ann Ind Aca Neu"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrl.2012.03.014","article-title":"The effect of intravenous immunoglobulin on neuromyelitis optica","volume":"28","author":"Magraner MJ","year":"2013","unstructured":"Magraner MJ, Coret F, Casanova B. The effect of intravenous immunoglobulin on neuromyelitis optica. Neurolog\u00eda. 2013, 28:65-72. 10.1016\/j.nrl.2012.03.014","journal-title":"Neurolog\u00eda"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of neuromyelitis optica in the United States: a multicenter analysis","volume":"69","author":"Mealy MA","year":"2012","unstructured":"Mealy MA, Wingerchuk DM, Greenberg BM, Levy M. Epidemiology of neuromyelitis optica in the United States: a multicenter analysis. Arch Neu. 2012, 69:1176-1180. 10.1001\/archneurol.2012.314","journal-title":"Arch Neu"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/396867-bilateral-ptosis-diplopia-and-vertical-gaze-palsy-an-unusual-presentation-of-adolescent-aquaporin-4-aqp4-antibody-positive-neuromyelitis-optica-spectrum-disorder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:26:40Z","timestamp":1757593600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/396867-bilateral-ptosis-diplopia-and-vertical-gaze-palsy-an-unusual-presentation-of-adolescent-aquaporin-4-aqp4-antibody-positive-neuromyelitis-optica-spectrum-disorder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.92051","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,11]]}}}